Large-Scale Ligand-Based Virtual Screening for SARS-CoV-2 Inhibitors Using Deep Neural Networks-Reference-Cited by-同舟云学术

Large-Scale Ligand-Based Virtual Screening for SARS-CoV-2 Inhibitors Using Deep Neural Networks

Published:2020 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Hofmarcher Markus,Mayr Andreas,Rumetshofer Elisabeth,Ruch Peter,Renz Philipp,Schimunek Johannes,Seidl Philipp,Vall Andreu,Widrich Michael,Hochreiter Sepp,Klambauer Günter

Publisher

Elsevier BV

Reference57 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs;T T Ashburn;Nature reviews Drug discovery,2004

2. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates

3. Two targets are better than one;J Collison;Nature Reviews Rheumatology,2019

4. Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 687 Million Compounds

5. The ChEMBL database in 2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Genomics in Psoriasis;International Journal of Molecular Sciences;2024-07-04

2. Innovative applications of artificial intelligence during the COVID-19 pandemic;Infectious Medicine;2024-03

3. Revolutionizing Vaccine Development for COVID-19: A Review of AI-Based Approaches;Information;2023-12-18

4. A Methodical Investigation into the COVID-19 Risk Prediction Models;2023 6th International Conference on Contemporary Computing and Informatics (IC3I);2023-09-14

5. Exploring the Intersection of Artificial Intelligence and Clinical Healthcare: A Multidisciplinary Review;Diagnostics;2023-06-07